Clinical Trials Market: Industry Consolidation and Mergers & Acquisitions

1
Clinical Trials Market Analysis, Revenue, Price,
Market Share, Growth Rate, Forecast to 2032
2

• Industry Insights

• Clinical Trials Market size is anticipated to
  record an appreciable valuation by 2032, owing to
  the increasing prospects for performing clinical
  trials in the Asia Pacific.
• The consistent rise in the burden of chronic
  disorders has accentuated the need for clinical
  trials in the region.
• As per the WHO, an estimated 25 million people
  are prediabetic in India. Escalating product
  innovations in the industry are further
  contributing to market expansion.
• For instance, in October 2022, ICON plc, a
  leading clinical research organization announced
  its selection by US Biomedical Advanced Research
  and Development Authority for conducting an
  anthrax vaccine clinical trial.

3

• The overall clinical trials industry is segmented
  in terms of phases, study design, therapeutic
  area, and region.
• Based on phases, the clinical trials market share
  from the phase I segment is expected to grow
  considerably through 2032. Phase I clinical trial
  results serve as the background for further
  progress in drug development.
• These studies examine the side effects, safety,
  and appropriate dosage level for patients.
  Furthermore, high efficacy of phase I clinical
  trials due to recent advancements in research
  methodologies is positively contributing to
  segment growth.
• Based on the study design, the market size from
  the observational study segment recorded more
  than USD 11 billion in 2022.
• The cost-effectiveness of observational studies
  over their interventional and expanded access
  counterparts will favor segment expansion. These
  studies are quick and provide researchers with
  insights into what occurs in real-life
  situations. Moreover, their usefulness in
  investigating rare outcomes and unusual side
  effects will boost their adoption in the next ten
  years.

4

• Regional Analysis

• Europe clinical trials industry is expected to be
  valued at over USD 23 billion by 2032. Rising
  number of clinical studies, along with favorable
  government support for clinical research, may
  contribute to regional expansion. In fact, the
  region is also home to many associations, such as
  the European CRO Federation (EUCROF), that
  provide high-quality clinical research.

• Competitive Analysis

• Thermo Fisher Scientific (PPD, Inc), Clinipace
  Inc, ICON plc, Charles River Laboratories (MPI
  Research), IQVIA, Medpace,Laboratory Corporation
  of America Holding (Covance Inc)

5
Clinical Trials Market _at_ https//www.gminsights.co
m/industry-analysis/clinical-trials-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/5
029
Request for customization _at_ https//www.gminsights
.com/roc/5029
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com